Digital cognitive behavioural therapy for insomnia and primary care costs in England: an interrupted time series analysis

Background: Sleepio is an automated digital program that delivers digital cognitive behavioural therapy for insomnia (dCBT-I). Sleepio has been proven effective in improving sleep difficulties; however, evidence for the possible impact of Sleepio use on healthcare costs in the UK has not, to the aut...

Full description

Bibliographic Details
Main Authors: Chris Sampson, Eleanor Bell, Amanda Cole, Christopher B Miller, Tracey Marriott, Matt Williams, James Rose
Format: Article
Language:English
Published: Royal College of General Practitioners 2022-06-01
Series:BJGP Open
Subjects:
Online Access:https://bjgpopen.org/content/6/2/BJGPO.2021.0146
_version_ 1818064220784164864
author Chris Sampson
Eleanor Bell
Amanda Cole
Christopher B Miller
Tracey Marriott
Matt Williams
James Rose
author_facet Chris Sampson
Eleanor Bell
Amanda Cole
Christopher B Miller
Tracey Marriott
Matt Williams
James Rose
author_sort Chris Sampson
collection DOAJ
description Background: Sleepio is an automated digital program that delivers digital cognitive behavioural therapy for insomnia (dCBT-I). Sleepio has been proven effective in improving sleep difficulties; however, evidence for the possible impact of Sleepio use on healthcare costs in the UK has not, to the authors’ knowledge, previously been developed. Aim: To identify the effect of a population-wide rollout of Sleepio in terms of primary care costs in the NHS in England. Design & setting: The study was conducted in the Thames Valley region of England, where access to Sleepio was made freely available to all residents between October 2018 and January 2020. The study relies on a quasi-experimental design, using an interrupted time series (ITS) to compare the trend in primary care costs before and after the rollout of Sleepio. Method: Primary care data for people with relevant characteristics from nine general practices in Buckinghamshire was used. Primary care costs include general practice contacts and prescriptions. Segmented regression analysis was used to estimate primary and secondary outcomes. Results: For the 10 705 patients included in the sample, the total saving over the 65-week follow-up period was £71 027. This corresponds to £6.64 per person in the sample or around £70.44 per Sleepio user. Secondary analyses suggest that savings may be driven primarily by reductions in prescribing. Conclusion: Sleepio rollout reduced primary care costs. National adoption of Sleepio may reduce primary care costs by £20 million in the first year. The expected impact on primary care costs in any particular setting will depend on the uptake of Sleepio.
first_indexed 2024-12-10T14:32:32Z
format Article
id doaj.art-0e7309362a014e3ca414a008985ecfb5
institution Directory Open Access Journal
issn 2398-3795
language English
last_indexed 2024-12-10T14:32:32Z
publishDate 2022-06-01
publisher Royal College of General Practitioners
record_format Article
series BJGP Open
spelling doaj.art-0e7309362a014e3ca414a008985ecfb52022-12-22T01:44:53ZengRoyal College of General PractitionersBJGP Open2398-37952022-06-016210.3399/BJGPO.2021.0146Digital cognitive behavioural therapy for insomnia and primary care costs in England: an interrupted time series analysisChris Sampson0Eleanor Bell1Amanda Cole2Christopher B Miller3Tracey Marriott4Matt Williams5James Rose6The Office of Health Economics, London, UKThe Office of Health Economics, London, UKThe Office of Health Economics, London, UKSleep and Circadian Neuroscience Institute, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UKOxford Academic Health Science Network, The Magdalen Centre, Oxford, UKOxford Academic Health Science Network, The Magdalen Centre, Oxford, UKOxford Academic Health Science Network, The Magdalen Centre, Oxford, UKBackground: Sleepio is an automated digital program that delivers digital cognitive behavioural therapy for insomnia (dCBT-I). Sleepio has been proven effective in improving sleep difficulties; however, evidence for the possible impact of Sleepio use on healthcare costs in the UK has not, to the authors’ knowledge, previously been developed. Aim: To identify the effect of a population-wide rollout of Sleepio in terms of primary care costs in the NHS in England. Design & setting: The study was conducted in the Thames Valley region of England, where access to Sleepio was made freely available to all residents between October 2018 and January 2020. The study relies on a quasi-experimental design, using an interrupted time series (ITS) to compare the trend in primary care costs before and after the rollout of Sleepio. Method: Primary care data for people with relevant characteristics from nine general practices in Buckinghamshire was used. Primary care costs include general practice contacts and prescriptions. Segmented regression analysis was used to estimate primary and secondary outcomes. Results: For the 10 705 patients included in the sample, the total saving over the 65-week follow-up period was £71 027. This corresponds to £6.64 per person in the sample or around £70.44 per Sleepio user. Secondary analyses suggest that savings may be driven primarily by reductions in prescribing. Conclusion: Sleepio rollout reduced primary care costs. National adoption of Sleepio may reduce primary care costs by £20 million in the first year. The expected impact on primary care costs in any particular setting will depend on the uptake of Sleepio.https://bjgpopen.org/content/6/2/BJGPO.2021.0146cognitive behavioural therapydigital technologyhealthcare costsinsomniainterrupted time series analysisprimary health care
spellingShingle Chris Sampson
Eleanor Bell
Amanda Cole
Christopher B Miller
Tracey Marriott
Matt Williams
James Rose
Digital cognitive behavioural therapy for insomnia and primary care costs in England: an interrupted time series analysis
BJGP Open
cognitive behavioural therapy
digital technology
healthcare costs
insomnia
interrupted time series analysis
primary health care
title Digital cognitive behavioural therapy for insomnia and primary care costs in England: an interrupted time series analysis
title_full Digital cognitive behavioural therapy for insomnia and primary care costs in England: an interrupted time series analysis
title_fullStr Digital cognitive behavioural therapy for insomnia and primary care costs in England: an interrupted time series analysis
title_full_unstemmed Digital cognitive behavioural therapy for insomnia and primary care costs in England: an interrupted time series analysis
title_short Digital cognitive behavioural therapy for insomnia and primary care costs in England: an interrupted time series analysis
title_sort digital cognitive behavioural therapy for insomnia and primary care costs in england an interrupted time series analysis
topic cognitive behavioural therapy
digital technology
healthcare costs
insomnia
interrupted time series analysis
primary health care
url https://bjgpopen.org/content/6/2/BJGPO.2021.0146
work_keys_str_mv AT chrissampson digitalcognitivebehaviouraltherapyforinsomniaandprimarycarecostsinenglandaninterruptedtimeseriesanalysis
AT eleanorbell digitalcognitivebehaviouraltherapyforinsomniaandprimarycarecostsinenglandaninterruptedtimeseriesanalysis
AT amandacole digitalcognitivebehaviouraltherapyforinsomniaandprimarycarecostsinenglandaninterruptedtimeseriesanalysis
AT christopherbmiller digitalcognitivebehaviouraltherapyforinsomniaandprimarycarecostsinenglandaninterruptedtimeseriesanalysis
AT traceymarriott digitalcognitivebehaviouraltherapyforinsomniaandprimarycarecostsinenglandaninterruptedtimeseriesanalysis
AT mattwilliams digitalcognitivebehaviouraltherapyforinsomniaandprimarycarecostsinenglandaninterruptedtimeseriesanalysis
AT jamesrose digitalcognitivebehaviouraltherapyforinsomniaandprimarycarecostsinenglandaninterruptedtimeseriesanalysis